本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BridgeBio Pharma, Inc.

66.39
+1.332.04%
成交量:153.95万
成交额:1.02亿
市值:127.94亿
市盈率:-15.87
高:67.71
开:64.00
低:63.91
收:65.06
52周最高:69.48
52周最低:21.72
股本:1.93亿
流通股本:1.51亿
量比:0.77
换手率:1.02%
股息:- -
股息率:- -
每股收益(TTM):-4.1844
每股收益(LYR):-2.8793
净资产收益率:-1789.67%
总资产收益率:-43.47%
市净率:-6.62
市盈率(LYR):-23.06

数据加载中...

2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/29

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/29

重要事件披露

Form 8-K - Current report
2025/10/29

重要事件披露

Form 8-K - Current report
2025/10/27

重要事件披露

Form 8-K - Current report
2025/10/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/05

重要事件披露

Form 8-K - Current report